Works matching Tuberculosis vaccines

Results: 2141
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.

    Published in:
    Clinical Infectious Diseases, 2015, v. 61, p. S102, doi. 10.1093/cid/civ609
    By:
    • Schito, Marco;
    • Migliori, Giovanni Battista;
    • Fletcher, Helen A.;
    • McNerney, Ruth;
    • Centis, Rosella;
    • D'Ambrosio, Lia;
    • Bates, Matthew;
    • Kibiki, Gibson;
    • Kapata, Nathan;
    • Corrah, Tumena;
    • Bomanji, Jamshed;
    • Vilaplana, Cris;
    • Johnson, Daniel;
    • Mwaba, Peter;
    • Maeurer, Markus;
    • Zumla, Alimuddin
    Publication type:
    Article
    16
    17
    18
    19

    Respiratory Immunization With a Whole Cell Inactivated Vaccine Induces Functional Mucosal Immunoglobulins Against Tuberculosis in Mice and Non-human Primates.

    Published in:
    Frontiers in Microbiology, 2020, v. 11, p. 1, doi. 10.3389/fmicb.2020.01339
    By:
    • Aguilo, Nacho;
    • Uranga, Santiago;
    • Mata, Elena;
    • Tarancon, Raquel;
    • Gómez, Ana Belén;
    • Marinova, Dessislava;
    • Otal, Isabel;
    • Monzón, Marta;
    • Badiola, Juan;
    • Montenegro, Dolores;
    • Puentes, Eugenia;
    • Rodríguez, Esteban;
    • Vervenne, Richard A. W.;
    • Sombroek, Claudia C.;
    • Verreck, Frank A. W.;
    • Martín, Carlos
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26

    Improving vaccines against tuberculosis.

    Published in:
    Immunology & Cell Biology, 2003, v. 81, n. 1, p. 34, doi. 10.1046/j.0818-9641.2002.01143.x
    By:
    • Britton, Warwick J;
    • Palendira, Umaimainthan
    Publication type:
    Article
    27
    28

    Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model.

    Published in:
    Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.799034
    By:
    • Gomez, Mellissa;
    • Ahmed, Mushtaq;
    • Das, Shibali;
    • McCollum, Joseph;
    • Mellett, Leah;
    • Swanson, Rosemary;
    • Gupta, Ananya;
    • Carrigy, Nicholas B.;
    • Wang, Hui;
    • Barona, David;
    • Bachchhav, Shital;
    • Gerhardt, Alana;
    • Press, Chris;
    • Archer, Michelle C.;
    • Liang, Hong;
    • Seydoux, Emilie;
    • Kramer, Ryan M.;
    • Kuehl, Philip J.;
    • Vehring, Reinhard;
    • Khader, Shabaana A.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.

    Published in:
    Vaccines, 2020, v. 8, n. 4, p. 652, doi. 10.3390/vaccines8040652
    By:
    • Tkachuk, Artem P.;
    • Bykonia, Evgeniia N.;
    • Popova, Liubov I.;
    • Kleymenov, Denis A.;
    • Semashko, Maria A.;
    • Chulanov, Vladimir P.;
    • Fitilev, Sergey B.;
    • Maksimov, Semyon L.;
    • Smolyarchuk, Elena A.;
    • Manuylov, Victor A.;
    • Vasina, Daria V.;
    • Gushchin, Vladimir A.;
    • Gintsburg, Alexander L.
    Publication type:
    Article
    41
    42
    43
    44

    An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials.

    Published in:
    Journal of Infectious Diseases, 2023, v. 228, n. 9, p. 1150, doi. 10.1093/infdis/jiad356
    By:
    • Hill, Philip C;
    • Cobelens, Frank;
    • Martinez, Leonardo;
    • Behr, Marcel A;
    • Churchyard, Gavin;
    • Evans, Tom;
    • Fiore-Gartland, Andrew J;
    • Garcia-Basteiro, Alberto L;
    • Hanekom, Willem;
    • Rangaka, Molebogeng X;
    • Vekemans, Johan;
    • White, Richard G
    Publication type:
    Article
    45

    Identification of antigens presented by MHC for vaccines against tuberculosis.

    Published in:
    NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-019-0148-y
    By:
    • Bettencourt, Paulo;
    • Müller, Julius;
    • Nicastri, Annalisa;
    • Cantillon, Daire;
    • Madhavan, Meera;
    • Charles, Philip D.;
    • Fotso, Carine B.;
    • Wittenberg, Rachel;
    • Bull, Naomi;
    • Pinpathomrat, Nawamin;
    • Waddell, Simon J.;
    • Stylianou, Elena;
    • Hill, Adrian V. S.;
    • Ternette, Nicola;
    • McShane, Helen
    Publication type:
    Article
    46

    The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial.

    Published in:
    NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0057-5
    By:
    • Coler, Rhea N.;
    • Day, Tracey A.;
    • Ellis, Ruth;
    • Piazza, Franco M.;
    • Beckmann, Anna Marie;
    • Vergara, Julie;
    • Rolf, Tom;
    • Lu, Lenette;
    • Alter, Galit;
    • Hokey, David;
    • Jayashankar, Lakshmi;
    • Walker, Robert;
    • Snowden, Margaret Ann;
    • Evans, Tom;
    • Ginsberg, Ann;
    • Reed, Steven G.
    Publication type:
    Article
    47
    48
    49
    50